EUVIMEDEUVIMED entdecken
Crossref

Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium

Masamichi Fukuda iD, Takeshi Kiyoi, Shun Takeda, Yu Sasaki, Takayoshi Masuoka, Eri Kubo, Hiroshi Sasaki

Journal of Ocular Pharmacology and Therapeutics · 2024

DOI: 10.1089/jop.2024.0025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Masamichi Fukuda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kanazawa Medical University, Kahoku, Japan. Hauptthemen laut MEDLINE: Diclofenac, Quinolones, Epithelium, Corneal, Ophthalmic Solutions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to investigate the relationship between diclofenac sodium ophthalmic solution (DFNa) and corneal epithelial cell damage and to evaluate the preventive effect of rebamipide (RBM) on it.

Methods

DFNa, DFNa/preservative-free (PF), or 0.5% chlorobutanol (CB) solution was instilled into the conjunctival sac of a normal rabbit eye, and corneal resistance measurement (using a corneal resistance device [CRD]) was performed 120 min after the end of instillation. Then, fluorescent staining (FL), corneal tissue staining (hematoxylin and eosin [H&E]), and immunostaining (zona occlusion-1) were performed (RBM-untreated group). However, RBM was instilled into the eyes of another group of normal rabbits, followed by each of the solutions; 120 min after the end of instillation, all evaluations were performed for this group (RBM treatment group).

Results

Using the CRD method, in the RBM-untreated group, corneal resistance (CR; %) was found to be significantly reduced in DFNa (79.9 ± 19.4%), DFNa/PF (89.1 ± 17.3%), and 0.5% CB (83.8 ± 10.6%). In addition, DFNa and 0.5% CB solutions showed positive staining in the FL staining method. In the H&E staining method, some clear voids were observed in the outermost layer of the cornea using DFNa and 0.5% CB solutions. However, corneal epithelial damage was suppressed in the RBM treatment group. ZO-1 immunostaining in DFNa and 0.5% CB solutions revealed discontinuous localization of ZO-1 at the cell periphery.

Conclusions

RBM eye drops were effective in preventing corneal epithelial damage caused by DFNa eye drops, and CB was considered to be the main causative agent of this damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiclofenacQuinolonesEpithelium, CornealOphthalmic SolutionsAlanineCorneal DiseasesAnimalsRabbitsAnti-Inflammatory Agents, Non-SteroidalMaleAdministration, Topical

Stichwörter der Autor:innen

chlorobutanolcorneal epithelial damagediclofenac Na ophthalmic solution

Substanzen

rebamipideDiclofenacQuinolonesOphthalmic SolutionsAlanineAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Ophthalmology, Kanazawa Medical University, Kahoku, Japan.
  • Department of Pharmacology, Kanazawa Medical University, Kahoku, Japan.

ORCID-Profile: Masamichi Fukuda

Zitieren

APA

Fukuda, M., Kiyoi, T., Takeda, S., Sasaki, Y., Masuoka, T., Kubo, E., & Sasaki, H. (2024). Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0025

Vancouver

Fukuda M, Kiyoi T, Takeda S, Sasaki Y, Masuoka T, Kubo E, et al. Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2024.0025

BibTeX
@article{Fukuda2024,
  author = {Fukuda, Masamichi and Kiyoi, Takeshi and Takeda, Shun and Sasaki, Yu and Masuoka, Takayoshi and Kubo, Eri and Sasaki, Hiroshi},
  title = {Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1089/jop.2024.0025}
}
Kostenlos starten →